Nitric oxide generation in brain cytosolic fractions markedly enhances ADP-ribosylation of a single 
Nitric oxide (NO) is a major biological messenger molecule accounting for endothelium-derived relaxing factor activity in blood vessels (1, 2) and the tumoricidal and bactericidal actions of macrophages (3) and serving a neurotransmitterlike role in the brain (4) . NO is synthesized from arginine by NO synthase (NOS). Distinct forms of NOS have been molecularly cloned from brain (5), macrophages (6) (7) (8) , and endothelium (9) . NO exerts some of its actions by stimulating guanylyl cyclase, which is not likely the sole physiologic target of NO, however. Thus, the localization of guanylyl cyclase protein and mRNA throughout the brain differs markedly from that of NOS (4, 10) . NO mediates the neurotoxicity of glutamate acting through N-methyl-D-aspartate receptors, as removal ofarginine from the incubation medium for brain cultures or treatment with NOS inhibitors prevents N-methyl-D-aspartate toxicity (11) . NO mediation of neurotoxicity does not involve guanylyl cyclase, as inhibitors ofthe enzyme fail to influence neurotoxicity, and 8-bromo-cGMP does not elicit neurotoxicity (12) .
In a search for alternative targets of NO, Brune and Lapetina (13) observed that NO can enhance ADPribosylation of a 37-kDa cytosolic protein. In the present study we have developed a biotinylated derivative of NAD, the substrate for ADP-ribosylation, and have isolated an NO-enhanced ADP-ribosylated protein (NAP) from brain tissue. We demonstrate that NAP is glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
MATERIALS AND METHODS
Preparation of Brain Extract. Adult rat brain was homogenized in ice-cold buffer (8 ml of buffer per g of brain) consisting of 20 mM Tris HCl (pH 7.4), 5 mM EDTA, 5 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride, chymostatin (1 ,ug/ml), leupeptin (1 ,ug/ml), pepstatin (1 .ug/ml), and trypsin inhibitor (1 tug/ml; all from Sigma). The homogenate was centrifuged at 100,000 x g for 40 min. The supernatant was used as cytosolic fraction for in vitro ADPribosylation.
We followed the published procedure for purification of NOS from rat cerebella (14) .
In Vitro ADP-Ribosylation of NAP. A typical ADPribosylation reaction mixture contained 10 (Fig. 1) . In control samples, radiolabel was incorporated most prominently into a 37-kDa band. Addition of SNP, which generates NO, substantially intensified this band, resembling results of others (13, 15, 16) . To ascertain whether generation of NO from endogenous sources can influence ADP-ribosylation, we added purified brain NOS to the specimens to increase labeling of the 37-kDa band. Nitroarginine, a potent NOS inhibitor, abolished the enhanced ADP-ribosylation produced by NOS. Indeed, nitroarginine-treated samples demonstrated negligible labeling of NAP even compared to control samples. In other experiments, nitroarginine added to brain samples without additional NOS also abolished labeling of NAP (data not shown). This establishes that endogenous NO can mediate ADP-ribosylation of NAP. As a potential reagent for purification of ADP-ribosylated proteins, we synthesized NAD with biotin attached to the ADP moiety at the sixth position. We utilized this biotinylated NAD as a substrate for ADP-ribosylation, visualizing ADP-ribosylated substrates with avidin-conjugated horseradish peroxidase (Fig. 2) . In the presence of SNP, we detected selective enhancement of ADP-ribosylation of a 37-kDa band whose labeling was abolished by exogenous NAD.
We purified NAP to homogeneity, taking advantage of the high solubility of NAP in ammonium sulfate so that it was recovered in the supernatant fraction after 65% ammonium sulfate precipitation (Fig. 3) (19) . X denotes an amino acid that could not be determined during sequencing. ribosylation involves linkages predominantly to arginine, lysine, asparagine, or cysteine. Hydroxylamine selectively reverses interactions with arginine in some proteins (17) , whereas mercuric chloride mainly abolishes interactions with cysteine (18) . Thus, ADP-ribosylation of NAP presumably occurs on cysteine.
We obtained the amino acid sequence of the N-terminal 29 amino acids by an automated Edman sequencing technique (Fig. 4) . The sequence is essentially identical to that of GAPDH. To ascertain whether NAP possesses GAPDH activity, we monitored the catalytic reduction of NAD to NADH upon oxidation of glyceraldehyde 3-phosphate (Fig.  5) . Purified NAP from the Superose 12 fraction displayed GAPDH activity with a specific activity for NAP protein identical to that for homogeneous GAPDH. Incubation ofthis fraction with avidin-agarose did not diminish GAPDH activity. This suggests that the biotinylated, and hence ADPribosylated, portion of isolated NAP does not contribute to GAPDH activity.
To confirm that GAPDH itself can be ADP-ribosylated, we utilized a preparation ofchicken muscle GAPDH (Fig. 6) . We detected ADP-ribosylation ofGAPDH in the absence ofbrain extract and in the absence of SNP. SNP produced a 15-fold enhanced labeling ofGAPDH. Deletion ofthymidine or Mg2+ markedly diminished both basal and SNP-stimulated ADPribosylation. We wondered whether chicken GAPDH preparation might be contaminated with an ADP-ribosyltransferase. Accordingly, we repeated these experiments with GAPDH from B. stearothermophilus purified by a different procedure than that used for chicken GAPDH. The same amount of ADP-ribosylation was observed with bacterial GAPDH and chicken GAPDH (data not shown). This establishes that GAPDH can auto-ADP-ribosylate and the process is enhanced by NO.
GAPDH is an NAD-dependent enzyme, suggesting that ADP-ribosylation occurs at the NAD recognition site. To determine whether ADP-ribosylation is a general feature of NAD-dependent dehydrogenases, we evaluated four other NAD-dependent dehydrogenases (Table 1) . Some ADPTime, min FIG. 5. Assaying NAP for GAPDH enzymatic activity. Purified NAP was incubated with glyceraldehyde 3-phosphate and NAD. The catalytic reduction of NAD to NADH was monitored by the increasing absorbance at 340 nm. The enzymatic activity was plotted as A3O vs. time. Each data point is an average of three experiments and the standard deviation is shown with an error bar. ribosylation of alcohol dehydrogenase was observed in the absence of SNP, but the level of labeling was less than 10%6 oflevels obtained with GAPDH. ADP-ribosylation of alcohol dehydrogenase was markedly enhanced by SNP. No ADPribosylation was evident in the absence or presence of SNP for glutamate dehydrogenase, lactate dehydrogenase, or malate dehydrogenase. This comparison demonstrates that GAPDH is selectively targeted for NO-enhanced ADPribosylation.
DISCUSSION
The major finding of this study is that NO-enhanced ADPribosylation in the brain involves GAPDH. GAPDH appears to be the only protein in the brain whose ADP-ribosylation is stimulated by NO. In peripheral tissues, Brune and Lapetina (13) have also found only a single 37-kDa protein whose ADP-ribosylation is enhanced by NO, and while this work was in preparation, Kots et al. (16) A particularly striking finding was that GAPDH is auto-ADP-ribosylated. Other known mammalian proteins that are ADP-ribosylated, such as guanine nucleotide binding proteins and elongation factor 2, do not auto-ADP-ribosylate (20) . Further, NO enhances the auto-ADP-ribosylation by acting either upon GAPDH or upon NAD to facilitate cleavage to ADP-ribose. In addition, Tanaka et al. (21) reported that ADP-ribose itself can directly attach to skeletal muscle GAPDH.
The reversal of GAPDH ADP-ribosylation by mercuric chloride indicates that ADP-ribosylation involves a cysteine in GAPDH. In the family of GAPDH proteins, only a single cysteine is conserved and this cysteine is located at the catalytic site of the enzyme and binds the NAD substrate (22 the same cysteine where the substrate NAD binds. Accordingly, ADP-ribosylation should terminate enzyme activity.
Does ADP-ribosylation physiologically regulate GAPDH? In our experiments, -5% of GAPDH is ADP-ribosylated. This is likely an underestimate, because NAD is known to bind tightly to GAPDH (23) and would compete with the labeled NAD that we add for ADP-ribosylation assays.
What might be physiologic functions of NO-mediated GAPDH ADP-ribosylation? The regional brain localization of guanylyl cyclase, one physiologic target of NO, differs markedly from NOS (10) and closely matches that of heme oxygenase 2, the enzyme that generates carbon monoxide (24) . Potent and selective inhibitors of heme oxygenase deplete endogenous cGMP in brain extracts, suggesting that carbon monoxide, rather than NO, is the principal endogenous regulator of cGMP levels in most parts of the brain. If GAPDH is ADP-ribosylated in vivo, then its isoelectric point (pI) should display heterogeneity, which is consistent with the observation that human brain GAPDH has subspecies with various pI values (25) .
GAPDH might mediate neurotoxicity associated with N-methyl-D-aspartate receptor activation and NO (11). cGMP is not likely involved in this process, as 8-bromocGMP does not elicit neurotoxicity and inhibitors ofguanylyl cyclase fail to block it (12) . Inhibition of GAPDH would diminish the amount of ATP formed from glycolysis and decrease the flow of substrates to the electron transport chain. These effects might produce a greater depletion of ATP than the NO-mediated inhibition of iron-sulfur proteins of the citric acid cycle and respiratory chain (3) .
Although ADP-ribosylation by bacterial toxins has been extensively elucidated, mammalian ADP-ribosyltransferases have only recently been characterized (20) and, heretofore, the best studied substrates have been elongation factor 2, guanine nucleotide binding proteins, and structural proteins.
GAPDH may provide a target whereby ADP-ribosylation could influence energy metabolism.
